The pharmacologic fate of the antitumor agent 2-amino-1,3,4-thiadiazole in the dog
- 1 November 1980
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 4 (4) , 275-279
- https://doi.org/10.1007/bf00255274
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Distribution and metabolism of 2-amino-1,3,4-thiadiazole in mice, dogs, and monkeys.1978
- Metabolism of a new herbicide, tebuthiuron {1‐[5‐(1,1‐dimethylethyl)‐1,3,4‐thiadiazol‐2‐yl]‐1,3‐dimethylurea}, in mouse, rat, rabbit, dog, duck, and fishJournal of Toxicology and Environmental Health, 1976
- Clinical pharmacologic observations on 6‐mercaptopurine and 6‐methylthiopurine ribonucleosideClinical Pharmacology & Therapeutics, 1968
- Session III: Secondary Hyperuricaemia: Allopurinol in the Prevention of Hyperuricaemia Secondary to the Treatmient of Neoplastic Diseases with Alkylating Agents, Adrenal Steroids, and Radiation TherapyAnnals of the Rheumatic Diseases, 1966
- STUDIES OF THE URICOGENIC EFFECT OF 2-SUBSTITUTED THIADIAZOLES IN MAN*Journal of Clinical Investigation, 1959
- Carbonic anhydrase inhibition. I. The pharmacology of diamox 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide.1954